Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 10, 2008, Pages 923-928

  Mikoluc, B ^a   Kayhty, H ^b   Bernatowska, E ^c   Motkowski, R ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ASPLENIA; CHILD; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; PNEUMOCOCCAL VACCINES; SPLEEN; YOUNG ADULT;

EID: 53549104127     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0523-5     Document Type: Article

References (32)

1. JD Dickerman 1979 Splenectomy and sepsis: a warning Pediatrics 63 938 941
2. DB Singers 1973 Postsplenectomy sepsis Perspect Pediatr Pathol 1 285 311
3. AM Lynch R Kapila 1996 Overwhelming postsplenectomy infection Infect Dis Clin North Am 10 693 707
4. V Sumaraju G Leon SM Smith 2001 Infectious complications in asplenic hosts Infect Dis Clin North Am 15 551 565
5. WP Hausdorff J Bryant PR Paradiso GR Siber 2000 Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. I Clin Infect Dis 30 100 121
6. GE Schutze EO Mason WJ Barson 2002 Invasive pneumococcal infections in children with asplenia Pediatr Infect Dis J 21 278 282
7. Lutwick LI (2000) Infections in asplenic patients. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious disease. Churchill Livingstone, Philadelphia, pp 3169-3176
8. RN Davidson RA Wall 2001 Prevention and management of infection in patients without a spleen Clin Microbiol Infect 7 657 666
9. American Academy of Pediatrics (2006) Immunocompromised children-asplenic children. The Red Book on CD-ROM, Report of the Committee on Infectious Disease, 27th edn. American Academy of Pediatrics, Elk Grove Village
10. DC Melles S de Marie 2004 Prevention of infections in hyposplenic and asplenic patients: an update Neth J Med 62 2 45 52
11. GL Cullingford DN Watkins AD Watt DF Mallon 1991 Severe late postsplenectomy infection Br J Surg 78 716 721
12. DN Williams B Kaur 1996 Postsplenectomy care. Strategies to decrease the risk of infection Postgrad Med 100 1 195 198
13. ML Brigden 2001 Detection, education and management of the asplenic or hyposplenic patient Am Family Physician 63 3 499 506
14. E Castagnola F Fioredda 2003 Prevention of life-threatening infections due to encapsula bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes Eur J Haematol 71 319 326
15. ACIP 2000 Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 49 RR-9 1 35
16. Canadian Pediatrics Society 1999 Prevention and therapy of bacterial infections for children with asplenia or hyposplenia Paediatr Child Health 4 6 417 421
17. World Health Organization 2005 Recommendations for the production and control of pneumococcal conjugate vaccines World Health Organ Tech Rep Se 927 Annex 2 64 98
18. S Black H Shinefield B Fireman 2000 Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Am J Manag Care 6 10 Suppl 536 549
19. FK Pedersen JL Nielsen J Ellegaard 1982 Antibody response to pneumococcal vaccine in splenectomized adults and adolescents Acta Pathol Microbiol Immunol Scand 90 257 263
20. GS Giebnik CT Le FG Cosio 1981 Serum antibody responses of high-risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae Rev Infect Dis 3 Suppl 168 178
21. JL Sullivan HD Ochs G Schiffman 1978 Immune response after splenectomy Lancet 1 8057 178 181
22. ES Caplan H Boltansky MJ Schnyder 1983 Response of traumatized splenectomized patients to immediate vaccination with polyvalent pneumococcal vaccine J Trauma 23 9 801 805
23. GR Siber 1997 Methods for estimating serologic correlates of protection Dev Biol Stand 89 283 296
24. JB Robbins R Austrian CJ Lee 1983 Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups J Infect Dis 148 1136 1159
25. K Sleeman K Knox R George 2001 Invasive pneumococcal disease in England and Wales: vaccination implications J Infect Dis 183 239 246
26. PA Shurin JM Rehmus CE Johnson 1993 Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high risk children J Pediatr 123 801 810
27. M Jugenburg G Haddock MH Freedman 1999 The morbidity and mortality of pediatric post splenectomy: does prophylaxis make a difference? J Pediatr Surg 34 7 1064 1067
28. A Skoczynska W Hryniewicz 2003 Genetic relatedness, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae responsible for meningitis in Poland, 1997-2001 Microb Drug Resist 9 2 175 182
29. A Finn R Booy R Moxon 2002 Should the new pneumococcal vaccine be used in high-risk children? Arch Dis Child 87 18 21
30. A Sulikowska P Grzesiowski E Sadowy 2004 Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated from the nasopharynges of asymptomatic children and molecular analysis of S. pneumoniae and H. influenzae strain replacement in the nasopharynx J Clin Microbiol 42 9 3942 3949
31. American Academy of Pediatrics 2000 Committee on infectious diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevenar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis Pediatrics 106 2 362 366
32. S Nachman S Kim J King EJ Abrams 2003 Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection Pediatrics 112 1 66